Vaxart, Inc. (VXRT) News Headlines

▮ More

Date

Headline

12/20/2018 8:13:18 PM AGEN Soars On GILD Deal, FENC Rolling Ahead, AIMT Gaining Steam

11/28/2018 8:10:10 PM ALQA's Subsidiary Enters Cannabis Space, TYME On Watch, VXRT Turning Heads

11/9/2018 8:49:48 AM Vaxart Q3 Net Loss $6.5 Mln Vs Net Loss $2.2 Mln Last Year

10/16/2018 9:40:07 PM CRMD On Watch, SPRO On Track To Initiate Phase 3 Trial, BMRA's Sales Drop

10/9/2018 11:15:10 PM TRVN Nearing D-Day, ABUS Skids On Study Delay, SNGX On Watch

6/6/2018 1:02:45 AM BIIB's Alzheimer's Drug Scores Well, EXAS Heads Higher, VXRT Down But Not Out

6/4/2018 7:13:44 AM Vaxart: Teslexivir Phase 2 Trial Fails To Meet Primary Efficacy Endpoint

6/4/2018 7:06:15 AM Vaxart Reports Phase 2 Trial Of Teslexivir Does Not Meet Primary Efficacy Endpoint

5/1/2018 8:04:12 AM Vaxart Appoints David Taylor As Chief Medical Officer

3/13/2018 9:16:02 PM GTHX Hits Record High, BVX Q4 Revenue Up 20%, ASNS Catches Eyes

3/5/2018 8:58:30 PM VCEL Shines On Q4 Results, CLSD's PEACHTREE Blooms, SBPH Waiting To ACHIEVE

1/11/2018 7:55:02 PM Aviragen Board Recommends Tht Stockholders Vote FOR Proposed Merger With Vaxart

12/22/2015 8:35:31 AM FBR Capital Markets Starts Biota Pharmaceuticals Inc. (BOTA) At Outperform With $6 Price Target

Older Articles